BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15500600)

  • 1. GP prescribing of nicotine replacement and bupropion to aid smoking cessation in England and Wales.
    McEwen A; West R; Owen L
    Addiction; 2004 Nov; 99(11):1470-4. PubMed ID: 15500600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. General practitioners' beliefs about effectiveness and intentions to prescribe smoking cessation medications: qualitative and quantitative studies.
    Vogt F; Hall S; Marteau TM
    BMC Public Health; 2006 Nov; 6():277. PubMed ID: 17092346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of the introduction of smoke-free legislation on prescribing of stop-smoking medications in England.
    Szatkowski L; Coleman T; McNeill A; Lewis S
    Addiction; 2011 Oct; 106(10):1827-34. PubMed ID: 21561500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescribing trends for nicotine replacement therapy in primary care.
    Tilson L; Bennett K; Barry M
    Ir Med J; 2004 Oct; 97(9):270-3. PubMed ID: 15568584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Australian smokers' use of bupropion and nicotine replacement therapies and their relation to reimbursement, Australia 2001-05.
    Lutsenko H; Doran CM; Hall WD
    Drug Alcohol Rev; 2008 Mar; 27(2):160-4. PubMed ID: 18264876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs to support smoking cessation in UK general practice: are evidence based guidelines being followed?
    Wilson A; Sinfield P; Rodgers S; Hammersley V; Coleman T
    Qual Saf Health Care; 2006 Aug; 15(4):284-8. PubMed ID: 16885254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. General Practitioners' views on the provision of nicotine replacement therapy and bupropion.
    McEwen A; West R; Owen L
    BMC Fam Pract; 2001; 2():6. PubMed ID: 11701091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking cessation treatment in primary care: prospective cohort study.
    Wilson A; Hippisley-Cox J; Coupland C; Coleman T; Britton J; Barrett S
    Tob Control; 2005 Aug; 14(4):242-6. PubMed ID: 16046686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia.
    Bertram MY; Lim SS; Wallace AL; Vos T
    Tob Control; 2007 Aug; 16(4):255-60. PubMed ID: 17652241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking cessation practices of Dutch general practitioners, cardiologists, and lung physicians.
    Kotz D; Wagena EJ; Wesseling G
    Respir Med; 2007 Mar; 101(3):568-73. PubMed ID: 16890419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. General practitioners' views on and referral to NHS smoking cessation services.
    McEwen A; West R; Owen L; Raw M
    Public Health; 2005 Apr; 119(4):262-8. PubMed ID: 15733685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial uptake and evidence of safe prescribing practice with Buproprion (Zyban).
    Williams D; Bennett K; Heery A; Feely J
    Pharmacoepidemiol Drug Saf; 2004 Jun; 13(6):411-5. PubMed ID: 15170772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supporting pregnant women to quit smoking: postal survey of New Zealand general practitioners and midwives' smoking cessation knowledge and practices.
    Glover M; Paynter J; Bullen C; Kristensen K
    N Z Med J; 2008 Mar; 121(1270):53-65. PubMed ID: 18364755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking cessation and nicotine replacement therapy in current primary maternity care.
    Pullon S; Webster M; McLeod D; Benn C; Morgan S
    Aust Fam Physician; 2004; 33(1-2):94-6. PubMed ID: 14988974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triggering anti-smoking advice by GPs: mode of action of an intervention stimulating smoking cessation advice by GPs.
    McEwen A; West R; Preston A
    Patient Educ Couns; 2006 Jul; 62(1):89-94. PubMed ID: 16023821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking cessation medication use among pregnant and postpartum smokers.
    Rigotti NA; Park ER; Chang Y; Regan S
    Obstet Gynecol; 2008 Feb; 111(2 Pt 1):348-55. PubMed ID: 18238972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population effectiveness of pharmaceutical aids for smoking cessation: what is associated with increased success?
    Gilpin EA; Messer K; Pierce JP
    Nicotine Tob Res; 2006 Oct; 8(5):661-9. PubMed ID: 17008193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacists on the front line in providing support for nicotine replacement therapy and bupropion purchasers.
    Paul CL; Tzelepis F; Walsh RA; Turner R
    Drug Alcohol Rev; 2007 Jul; 26(4):429-33. PubMed ID: 17564880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of selectors of nicotine replacement therapy.
    Shiffman S; Di Marino ME; Sweeney CT
    Tob Control; 2005 Oct; 14(5):346-55. PubMed ID: 16183986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.